BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 30058665)

  • 1. Biomonitoring of occupational exposure to 5-FU by assaying α-fluoro-β-alanine in urine with a highly sensitive UHPLC-MS/MS method.
    Dhersin A; Atgé B; Martinez B; Titier K; Rousset M; Sidatt Cheikh El Moustaph M; Verdun-Esquer C; Molimard M; Villa A; Canal-Raffin M
    Analyst; 2018 Aug; 143(17):4110-4117. PubMed ID: 30058665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological monitoring of occupational exposure to 5-fluorouracil: urinary α-fluoro-β-alanine assay by high performance liquid chromatography tandem mass spectrometry in health care personnel.
    Ndaw S; Denis F; Marsan P; d'Almeida A; Robert A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Oct; 878(27):2630-4. PubMed ID: 20207593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A highly sensitive UHPLC-MS/MS method for urine biological monitoring of occupational exposure to anthracycline antineoplastic drugs and routine application.
    Villa A; Tremolet K; Martinez B; Da Silva Cacao O; Atgé B; Ducint D; Titier-Debeaupuis K; Verdun-Esquer C; Molimard M; Canal-Raffin M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Nov; 1156():122305. PubMed ID: 32987297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new, sensitive and versatile assay for quantitative determination of α-fluoro-β-alanine (AFBA) in human urine by using the reversed-phase ultrahigh performance-tandem mass spectrometry (rp-UHPLC-MS/MS) system.
    Sottani C; Grignani E; Zaratin L; Santorelli D; Studioso E; Lonati D; Locatelli CA; Pastoris O; Negri S; Cottica D
    Toxicol Lett; 2018 Dec; 298():164-170. PubMed ID: 30315949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assay of urinary alpha-fluoro-beta-alanine by gas chromatography-mass spectrometry for the biological monitoring of occupational exposure to 5-fluorouracil in oncology nurses and pharmacy technicians.
    Rubino FM; Verduci C; Buratti M; Fustinoni S; Campo L; Omodeo-Salè E; Giglio M; Iavicoli S; Brambilla G; Colombi A
    Biomed Chromatogr; 2006 Mar; 20(3):257-66. PubMed ID: 16167301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urine biomonitoring of occupational exposure to methotrexate using a highly sensitive UHPLC-MS/MS method in MRM
    Villa A; Tremolet K; Martinez B; Petit M; Dascon X; Stanek J; Ducint D; Titier-Debeaupuis K; Verdun-Esquer C; Molimard M; Canal-Raffin M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Oct; 1209():123411. PubMed ID: 35985163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A direct, sensitive and efficient method for determination of alpha-fluoro-beta-alanine in urine: Evaluating the influence of magnesium isoglycyrrhizinate on excretion in rat model.
    Wang Z; Yang Y; Zhang F; Li M; Chen J; Man H; Jiang W; Zhang R; Gao S; Chen W
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Dec; 1102-1103():17-22. PubMed ID: 30366208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a UPLC-MS/MS Assay for the Quantitative Determination of Capecitabine, 5'-deoxy-5-fluorocytidine (5'-dFCR), 5'-deoxy-5-fluorouridine (5'-dFUR), 5'-fluorouracil (5-FU), and α-fluoro-β-alanine (FBAL).
    Knikman JE; de Vries N; Rosing H; Cats A; Guchelaar HJ; Beijnen JH
    Pharmazie; 2023 Aug; 78(8):107-112. PubMed ID: 37592424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly sensitive LC-MS/MS methods for urinary biological monitoring of occupational exposure to cyclophosphamide, ifosfamide, and methotrexate antineoplastic drugs and routine application.
    Canal-Raffin M; Khennoufa K; Martinez B; Goujon Y; Folch C; Ducint D; Titier K; Brochard P; Verdun-Esquer C; Molimard M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Oct; ():. PubMed ID: 28029545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of occupational exposure of pharmaceutical plant workers to 5-fluorouracil. Determination of alpha-fluoro-beta-alanine in urine.
    Sessink PJ; Timmersmans JL; Anzion RB; Bos RP
    J Occup Med; 1994 Jan; 36(1):79-83. PubMed ID: 8138854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Occupational exposures among nurses caring for chemotherapy patients -Quantitative analysis of cyclophosphamide and α-fluoro-β-alanine in urine].
    Sasaki M; Ishii N; Kikuchi Y; Kudoh Y; Sugiyama R; Hasebe M
    Sangyo Eiseigaku Zasshi; 2016 Oct; 58(5):164-172. PubMed ID: 27488511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a sensitive and selective LC-MS/MS method for the determination of alpha-fluoro-beta-alanine, 5-fluorouracil and capecitabine in human plasma.
    Licea-Perez H; Wang S; Bowen C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Apr; 877(11-12):1040-6. PubMed ID: 19285927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development, validation and application of a novel liquid chromatography tandem mass spectrometry assay measuring uracil, 5,6-dihydrouracil, 5-fluorouracil, 5,6-dihydro-5-fluorouracil, α-fluoro-β-ureidopropionic acid and α-fluoro-β-alanine in human plasma.
    Chavani O; Jensen BP; Strother RM; Florkowski CM; George PM
    J Pharm Biomed Anal; 2017 Aug; 142():125-135. PubMed ID: 28501750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for the human biomonitoring of non-occupational exposure to the fragrance 2-(4-tert-butylbenzyl)propionaldehyde (lysmeral).
    Pluym N; Krnac D; Gilch G; Scherer M; Leibold E; Scherer G
    Anal Bioanal Chem; 2016 Aug; 408(21):5873-5882. PubMed ID: 27370687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Excretion of 1-hexylcarbamoyl-5-fluorouracil in urine of mice.
    Iigo M; Nakamura A; Kuretani K; Hoshi A
    J Pharmacobiodyn; 1981 Jul; 4(7):490-6. PubMed ID: 6795334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pilot study of biological monitoring of four antineoplastic drugs among Canadian healthcare workers.
    Poupeau C; Tanguay C; Plante C; Gagné S; Caron N; Bussières JF
    J Oncol Pharm Pract; 2017 Jul; 23(5):323-332. PubMed ID: 27084515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UPLC-MS/MS method for simultaneous determination of cyclophosphamide, docetaxel, doxorubicin and 5-fluorouracil in surface samples.
    da Silva CB; Julio IP; Donadel GE; Martins I
    J Pharmacol Toxicol Methods; 2016; 82():68-73. PubMed ID: 27521053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of healthcare workers' exposure to cyclophosphamide, ifosfamide, methotrexate, and 5-fluorouracil by 24-h urine assay: A descriptive pilot study.
    Palamini M; Dufour A; Therrien R; Delisle JF; Mercier G; Gagné S; Caron N; Bussières JF
    J Oncol Pharm Pract; 2020 Dec; 26(8):1864-1870. PubMed ID: 32138611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antineoplastic drugs determination by HPLC-HRMS(n) to monitor occupational exposure.
    Dal Bello F; Santoro V; Scarpino V; Martano C; Aigotti R; Chiappa A; Davoli E; Medana C
    Drug Test Anal; 2016 Jul; 8(7):730-7. PubMed ID: 26041114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous quantification of four metabolites of sulfur mustard in urine samples by ultra-high performance liquid chromatography-tandem mass spectrometry after solid phase extraction.
    Liu CC; Liu SL; Xi HL; Yu HL; Zhou SK; Huang GL; Liang LH; Liu JQ
    J Chromatogr A; 2017 Apr; 1492():41-48. PubMed ID: 28284764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.